BobesJArangoCGarcia-GarciaMRejasJ; CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry. 2010;71:280-286. doi:10.4088/JCP.08m 04250yel.
2.
MessingerJWTrémeauFAntoniusDet al. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin Psychol Rev. 2011;31:161-168. doi:10.1016/j.cpr.2010.09.002.
3.
HarveyPDStrassnigM.Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry. 2012;11:73-79.
4.
GalderisiSRossiARoccaPet al; Italian Network For Research on Psychoses. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014;13:275-287. doi:10.1002/wps.20167.
5.
MucciAMerlottiEÜcokAAlemanAGalderisiS.Primary and persistent negative symptoms: concepts, assessments, and neurobiological bases. Schizophr Res. 2017;186:19-28. doi:10.1016/j.schres.2016.05.014.
6.
GalderisiSFardenAKaiserS.Dissecting negative symptoms of schizophrenia: History, assessment, pathophysiological mechanisms, and treatment. Schizophr Res. 2017;186:1-2. doi:10.1016/j.schres.2016.04.046.
7.
KirkpatrickBMucciAGalderisiS.Primary, enduring negative symptoms: an update on research. Schizophr Bull. 2017;43:730-736. doi:10.1093/schbul/sbx064.
8.
AlemanALincolnTMBruggemanRet al. Treatment of negative symptoms: where do we stand, and where do we go?Schizophr Res. 2017;186:55-62. doi:10.1016/j.schres.2016.05.015.
KringAMGurREBlanchardJJHoranWPReiseSP.The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170:165-172. doi:10.1176/appi.ajp.2012.12010109.
12.
MarderSRGalderisiS.The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16:14-24. doi:10.1002/wps.20385.
13.
LiemburgECasteleinSStewartRvan der GaagMAlemanAKnegteringH; Genetic Risk and Outcome of Psychosis (GROUP) Investigators. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J Psychiatr Res. 2013;47:718-725. doi:10.1016/j.jpsy chires.2013.01.024.
14.
PeraltaVCuestaMJ.Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophr Res. 1999;40:245-253.
15.
LyneJRenwickLGrantTet al. Scale for the Assessment of Negative Symptoms structure in first episode psychosis. Psychiatry Res. 2013;210:1191-1197. doi:10.1016/j.psychres.2013.09.008.
16.
ErgülCÜcokA.Negative symptom subgroups have different effects on the clinical course of schizophrenia after the first episode: a 24-month follow up study. Eur Psychiatry. 2015;30:14-19. doi:10.1016/j.eurpsy.2014.07.005.
17.
StraussGPHoranWPKirkpatrickBet al. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res. 2013;47:783-790. doi:10.1016/j.jpsy chires.2013.01.015.
18.
MucciAGalderisiSMerlottiEet al. The Brief Negative Symptom Scale (BNSS): independent validation in a large sample of Italian patients with schizophrenia. Eur Psychiatry. 2015;30:641-647. doi:10.1016/j.eurpsy.2015.01.014.
19.
KirschnerMAlemanAKaiserS.Secondary negative symptoms—a review of mechanisms, assessment, and treatment. Schizophr Res. 2017;186:29-38. doi:10.1016/j.schres .2016.05.003.
